OncoLink Cancer Treatment and Resources
Link to OncoLink

Malignant Mixed Mullerian Tumor (MMMT) of the Ovary

Ultima Vez Modificado: 14 de diciembre del 2003

Question

Dear OncoLink "Ask The Experts,"
My mother (63 y.o.) was recently diagnosed with a multi-mullerian ovarian tumor. She had a complete hysterectomy and 21 biopsies. The tumor was on her right ovary and spread to her fallopian tube. She is staged at 2-a. I am aware that this type of cancer is rare and that there aren't a lot of statistically significant studies on it. Even less frequently is it caught in stage 2a.

Her doctor has recommended a treatment plan of 8 cycles of Chemo. The plan he has recommended is known as "doubling." She will alternate in her 8 treatments between the gold standard of Taxol / Carbo and a second set of drugs know as Ifos / Adria. She will receive four treatments of each.

My mom is obviously scared about Chemo because of the fact that there is no concrete evidence that her body isn't currently free of cancer. Is there any light that you can shed on the type of treatment that her Doctor has recommended? Also, is there any advice that you can give on this situation or on where I can go to get good literature on it? We want to get educated as a family so that we can get my mom comfortable with the final treatment program.  

Answer

Christina S. Chu, MD, Assistant Professor of the Division of Gynecologic Oncology at the University of Pennsylvania Health System, responds:

Malignant mixed Mullerian tumor (MMMT) of the ovary is very rare. These tumors more commonly occur in the uterus, but even then are rare. We know from clinical trials that several chemotherapies have activity against this tumor including the drugs that your physicians recommended: paclitaxel (Taxol), adriamycin (also known as doxorubicin), ifosfamide, cisplatin and carboplatin. These drugs can be given in various combinations and schedules, which should be discussed in detail with your physicians. However, because these tumors may be very aggressive, I agree that your mother should receive additional chemotherapy. If you wish to investigate more about this type of tumor, I would advise that you research MMMT (also known as carcinosarcoma) of the uterus, which is more common. We believe that any information regarding chemotherapy effectiveness for tumors of the uterus should also hold true for tumors of the ovary.

OncoLink I wish u knew...

Ms. Schafer discusses the role of the chaplain and spirituality in cancer care. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS